Cholesterol metabolism in immune cells linked to HIV progression
20 July 2015 | By Victoria White
Lower levels of cholesterol in certain immune cells may help explain why some HIV-infected people are able to naturally control disease progression...
List view / Grid view
News
Cellecta receives NIH grant to develop CRISPR knockout library of guide RNA sequences
20 July 2015 | By Victoria White
Cellecta has announced the receipt of Phase I SBIR grant funds from the NIH to further its CRISPR-mediated genome-editing library...
In Conversation – Thoughts on the current status of the sequencing industry. An interview with Jacqueline Boultwood, University of Oxford
17 July 2015 | By Oxford Global
In the run up to our 2015 Next Generation Sequencing Congress, Single Cell Congress & Genome Editing Congress we spoke with Jacqueline Boultwood, University of Oxford...
Teva to share a case study on how Biosimilarity has supported their Biosimilar projects | Biosimilars and Biobetters
17 July 2015 | By Biosimilars and Biobetters
This year's conference will address recent regulatory updates, pharmacovigilance of biosimilars, patent litigation, market access & global market developments...
Anti-malaria drugs could be a potential treatment for Parkinson’s disease
17 July 2015 | By Victoria White
Scientists have found that existing anti-malaria drugs, Chloroquine and Amodiaquine, could be a potential treatment for Parkinson's disease...
Novogen’s Anisina receives Orphan Drug Designation from FDA for neuroblastoma
16 July 2015 | By Victoria White
Novogen has received notification FDA that its chemotherapy candidate drug, Anisina, has been granted Orphan Drug Designation for neuroblastoma...
Achaogen awarded $4.5 million contract to advance LpxC inhibitors
16 July 2015 | By Victoria White
Achaogen has been awarded a $4.5 million contract for the discovery and development of LpxC inhibitors for the treatment of bacterial infections...
Two Stat3 inhibitors show potential in fighting brain and breast cancers
16 July 2015 | By Victoria White
Researchers have discovered two chemical compounds that effectively stop the growth of brain cancer cells and breast tumours by inhibiting the Stat3 protein...
New resource makes CRISPR/Cas9 technology even more user friendly
16 July 2015 | By Victoria White
Researchers have developed a user-friendly resource to accompany the powerful CRISPR/Cas9 tool, which has been widely adopted to make precise changes in DNA...
Galapagos licenses HUB Organoid Technology for use in cystic fibrosis and IBD research
15 July 2015 | By Victoria White
Galapagos has entered into a licensing agreement with the HUB foundation for use of Organoid Technology for preclinical research in cystic fibrosis and IBD...
MUSC and Bristol-Myers Squibb announce research collaboration focused on fibrotic diseases
15 July 2015 | By Victoria White
MUSC and Bristol-Myers Squibb have entered into a research collaboration focused on fibrotic diseases, including scleroderma and renal fibrosis...
Gene therapy gives long-term protection to photoreceptor cells in retinitis pigmentosa model
15 July 2015 | By Victoria White
Scientists have shown that gene therapy can give protection to the light-sensitive photoreceptor cells responsible for colour vision in retinitis pigmentosa...
MRC, GSK and five leading UK universities collaborate to crack difficult disease areas
15 July 2015 | By Victoria White
GSK and MRC are to collaborate on a unique open innovation research initiative aiming to improve scientists’ understanding of inflammatory diseases...
Stem cells might heal damaged lungs
15 July 2015 | By Victoria White
Weizmann Institute scientists have shown how it might be possible to use embryonic stem cells to repair damaged lung tissue...
The Francis Crick Institute and GSK join forces to forge new scientific discoveries
14 July 2015 | By Victoria White
The Francis Crick Institute and GSK are to partner up to explore new avenues of medical research and drug discovery across a broad range of diseases...
